Alexandra Heurgué

3.5k total citations · 1 hit paper
17 papers, 506 citations indexed

About

Alexandra Heurgué is a scholar working on Hepatology, Epidemiology and Surgery. According to data from OpenAlex, Alexandra Heurgué has authored 17 papers receiving a total of 506 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Hepatology, 11 papers in Epidemiology and 8 papers in Surgery. Recurrent topics in Alexandra Heurgué's work include Liver Disease Diagnosis and Treatment (8 papers), Liver Diseases and Immunity (6 papers) and Hepatocellular Carcinoma Treatment and Prognosis (4 papers). Alexandra Heurgué is often cited by papers focused on Liver Disease Diagnosis and Treatment (8 papers), Liver Diseases and Immunity (6 papers) and Hepatocellular Carcinoma Treatment and Prognosis (4 papers). Alexandra Heurgué collaborates with scholars based in France, Spain and Italy. Alexandra Heurgué's co-authors include Gérard Thiéfin, George Lau, Stephen L. Chan, Alexander Vasilyev, Bruno Sangro, Kabir Mody, Brigitte Bernard‐Chabert, Ghassan K. Abou‐Alfa, Robin Kate Kelley and Philip He and has published in prestigious journals such as Journal of Clinical Oncology, Hepatology and Journal of Hepatology.

In The Last Decade

Alexandra Heurgué

15 papers receiving 502 citations

Hit Papers

Phase 3 randomized, open-label, multicenter study of trem... 2022 2026 2023 2024 2022 50 100 150 200 250
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Phase 3 randomized, open-label, multicenter study of tremelimumab (T) and durvalumab (D) as first-line therapy in patients (pts) with unresectable hepatocellular carcinoma (uHCC): HIMALAYA.
    2022 259 citations Ghassan K. Abou‐Alfa, Stephen L. Chan et al. Journal of Clinical Oncology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Alexandra Heurgué France 7 322 174 153 101 85 17 506
Toru Arano Japan 8 539 1.7× 411 2.4× 128 0.8× 200 2.0× 107 1.3× 17 745
Taisuke Ueda Japan 14 694 2.2× 480 2.8× 49 0.3× 120 1.2× 57 0.7× 19 793
Noritaka Wakui Japan 10 247 0.8× 184 1.1× 55 0.4× 92 0.9× 56 0.7× 70 398
Xiaohong Zhang China 10 235 0.7× 136 0.8× 41 0.3× 67 0.7× 37 0.4× 40 428
Jean Claude Trinchet France 10 755 2.3× 574 3.3× 110 0.7× 219 2.2× 71 0.8× 11 895
Eriko Goto Japan 13 696 2.2× 679 3.9× 112 0.7× 126 1.2× 63 0.7× 23 920
Shusuke Kitabatake Japan 12 366 1.1× 351 2.0× 59 0.4× 122 1.2× 93 1.1× 18 549
Annalisa Ardiri Italy 13 335 1.0× 213 1.2× 127 0.8× 226 2.2× 56 0.7× 19 639
Edward Mena United States 14 364 1.1× 471 2.7× 79 0.5× 123 1.2× 47 0.6× 28 696

Countries citing papers authored by Alexandra Heurgué

Since Specialization
Citations

This map shows the geographic impact of Alexandra Heurgué's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alexandra Heurgué with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alexandra Heurgué more than expected).

Fields of papers citing papers by Alexandra Heurgué

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alexandra Heurgué. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alexandra Heurgué. The network helps show where Alexandra Heurgué may publish in the future.

Co-authorship network of co-authors of Alexandra Heurgué

This figure shows the co-authorship network connecting the top 25 collaborators of Alexandra Heurgué. A scholar is included among the top collaborators of Alexandra Heurgué based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alexandra Heurgué. Alexandra Heurgué is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Maan, Raoel, Mandy N. Lauw, David Patch, et al.. (2024). Extensive splanchnic vein thrombosis after SARS-CoV-2 vaccination: A Vascular Liver Disease Group (VALDIG) initiative. Hepatology. 80(5). 1147–1157. 1 indexed citations
2.
Sangro, Bruno, George Lau, Masatoshi Kudo, et al.. (2023). 147P Four-year overall survival (OS) update from the phase III HIMALAYA study of tremelimumab plus durvalumab in unresectable hepatocellular carcinoma (uHCC). Annals of Oncology. 34. S1530–S1531. 1 indexed citations
3.
Abou‐Alfa, Ghassan K., Stephen L. Chan, Masatoshi Kudo, et al.. (2022). Phase 3 randomized, open-label, multicenter study of tremelimumab (T) and durvalumab (D) as first-line therapy in patients (pts) with unresectable hepatocellular carcinoma (uHCC): HIMALAYA.. Journal of Clinical Oncology. 40(4_suppl). 379–379. 259 indexed citations breakdown →
4.
Corpechot, Christophe, Alexandra Heurgué, Pascal Potier, et al.. (2021). Non-invasive diagnosis and follow-up of primary biliary cholangitis. Clinics and Research in Hepatology and Gastroenterology. 46(1). 101770–101770. 5 indexed citations
5.
Chazouillères, Olivier, Pascal Potier, Alexandra Heurgué, et al.. (2021). Non-invasive diagnosis and follow-up of primary sclerosing cholangitis. Clinics and Research in Hepatology and Gastroenterology. 46(1). 101775–101775. 4 indexed citations
6.
Lemoinne, Sara, Alexandra Heurgué, Jérôme Gournay, et al.. (2021). Non-invasive diagnosis and follow-up of autoimmune hepatitis. Clinics and Research in Hepatology and Gastroenterology. 46(1). 101772–101772. 4 indexed citations
7.
Heurgué, Alexandra, Dalila Habès, Mathias Brügel, et al.. (2020). Recent (non-cirrhotic) extrahepatic portal vein obstruction. Clinics and Research in Hepatology and Gastroenterology. 44(4). 460–465.
8.
Shukla, Akash, Christophe Bureau, Marco Senzolo, et al.. (2018). Pregnancy in idiopathic non-cirrhotic portal hypertension: A multicentric study on maternal and fetal management and outcome. Journal of Hepatology. 69(6). 1242–1249. 23 indexed citations
9.
Dramé, Moustapha, Alexandra Heurgué, Tullio Piardi, et al.. (2018). Absence de lien entre la densité de médecins généralistes et la survie des patients atteints de carcinome hépatocellulaire. Santé Publique. Vol. 30(5). 679–687. 1 indexed citations
10.
Adenis, Antoine, Olivier Bouché, Alain Duhamel, et al.. (2016). Signet Ring Cells and Efficacy of First-line Chemotherapy in Advanced Gastric or Oesogastric Junction Adenocarcinoma. Anticancer Research. 36(10). 5543–5550. 22 indexed citations
11.
Attali, JR, et al.. (2014). Computed tomography follow-up of acute portal vein thrombosis. Diagnostic and Interventional Imaging. 95(6). 579–585. 4 indexed citations
12.
Zhang, Xiaoqing, Gérard Thiéfin, Cyril Gobinet, et al.. (2013). Profiling serologic biomarkers in cirrhotic patients via high-throughput Fourier transform infrared spectroscopy: toward a new diagnostic tool of hepatocellular carcinoma. Translational research. 162(5). 279–286. 32 indexed citations
13.
Thiéfin, Gérard, Cyril Gobinet, Valérie Untereiner, et al.. (2013). Diagnosis of hepatocellular carcinoma in cirrhotic patients: a proof-of-concept study using serum micro-Raman spectroscopy. The Analyst. 138(14). 4006–4006. 50 indexed citations
14.
Heurgué, Alexandra, et al.. (2009). Overlap syndrome triggered by acute viral hepatitis A. European Journal of Gastroenterology & Hepatology. 21(6). 708–709. 2 indexed citations
15.
Thiéfin, Gérard, et al.. (2008). Infliximab-induced hepatitis: absence of cross-toxicity with etanercept. Joint Bone Spine. 75(6). 737–739. 39 indexed citations
16.
Heurgué, Alexandra, Fabien Vitry, Marie-Danièle Diébold, et al.. (2007). Overlap syndrome of primary biliary cirrhosis and autoimmune hepatitis: a retrospective study of 115 cases of autoimmune liver disease. Gastroentérologie Clinique et Biologique. 31(1). 17–25. 55 indexed citations
17.
Heurgué, Alexandra, Brigitte Bernard‐Chabert, Thierry Higuero, et al.. (2004). Atteinte hépatique aiguë cholestatique induite par le glimépiride. Annales d Endocrinologie. 65(2). 174–175. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Toru Arano Breakdown of academic impact, for papers by Taisuke Ueda Breakdown of academic impact, for papers by Noritaka Wakui Breakdown of academic impact, for papers by Xiaohong Zhang Breakdown of academic impact, for papers by Jean Claude Trinchet Breakdown of academic impact, for papers by Eriko Goto Breakdown of academic impact, for papers by Shusuke Kitabatake Breakdown of academic impact, for papers by Annalisa Ardiri Breakdown of academic impact, for papers by Edward Mena
Rankless by CCL
2026